Platelet-derived CXC chemokines: old players in new games

被引:136
|
作者
Brandt, E [1 ]
Ludwig, A [1 ]
Petersen, F [1 ]
Flad, HD [1 ]
机构
[1] Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany
关键词
D O I
10.1034/j.1600-065X.2000.17705.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although platelet factor 4 (PF-4) and the beta -thromboglobulin (beta -TG) proteins represent the first chemokines to be discovered, their functional roles in host defense became clear only recently. Residing in platelets as storage proteins and becoming released into the blood at very high concentrations, these mediators appear to fulfill different and complementary tasks as first-line mediators in the recruitment and activation of leukocytes, as well in the regulation of tissue repair. Whereas both proteins are structurally closely related members of the CXC chemokine subfamily, they are subject to quite dissimilar regulatory mechanisms controlling their generation and their spectrum of biological activities. Thus, proteolytic processing of inactive precursors plays a decisive role in whether the beta -TG proteins will act as stimulatory or inhibitory agents in neutrophil activation via the G protein-coupled receptors CXCR-1 and 2. PF-4, existing as a single molecular form, is largely resistant to proteolytic modification, but its interaction with an unusual recepror(s) on leukocytes (a proteoglycan) appears to depend on its oligomeric stare. There is growing evidence that both chemokines may interfere with each other at various regulatory levels to promote coordinated cell activation. Moreover, recent findings suggest novel and unexpected activities for these chemokines, which may extend our view on early host defense.
引用
收藏
页码:204 / 216
页数:13
相关论文
共 50 条
  • [41] Platelet-derived microparticles and platelet count in preterm newborns
    Wasiluk, Alicja
    Mantur, Maria
    Szczepanski, Marek
    Matowicka-Karna, Joanna
    Kemona, Halina
    Warda, Janusz
    FETAL DIAGNOSIS AND THERAPY, 2008, 23 (02) : 149 - 152
  • [42] Association of platelet-derived microparticles with C-C chemokines on vascular complication in patients with acute myocardial infarction
    Matsumoto, N
    Nomura, S
    Kamihata, H
    Kimura, Y
    Iwasaka, T
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2002, 8 (03) : 279 - 286
  • [43] CXC chemokines: A new family of heat-shock proteins?
    Nagarsekar, A
    Hasday, JD
    Singh, IS
    IMMUNOLOGICAL INVESTIGATIONS, 2005, 34 (03) : 381 - 398
  • [44] PLANT FOOD CY-3-G ATTENUATES PLATELET-DERIVED CHEMOKINES AND CHEMOKINE RECEPTORS ON LEUCOCYTE IN ATHEROSCLEROSIS
    Yao, Yanling
    Zhang, Xiandan
    Zhou, Fanghang
    Ling, Wenhua
    Yang, Yan
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 127 - 127
  • [45] PLATELET-DERIVED GROWTH-FACTOR
    MEYERINGOLD, W
    EICHNER, W
    CELL BIOLOGY INTERNATIONAL, 1995, 19 (05) : 389 - 398
  • [46] PLATELET-DERIVED GROWTH-FACTORS
    MIYAZONO, K
    TAKAKU, F
    BLOOD REVIEWS, 1989, 3 (04) : 269 - 276
  • [47] PLATELET-DERIVED GROWTH-FACTOR
    ROSS, R
    BOWENPOPE, D
    RAINES, E
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1984, 20 (03): : 280 - 280
  • [48] Platelet-Derived Microvesicles in Cardiovascular Diseases
    Zaldivia, Maria T. K.
    McFadyen, James D.
    Lim, Bock
    Wang, Xiaowei
    Peter, Karlheinz
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2017, 4
  • [49] New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus
    Marc Scherlinger
    Vanja Sisirak
    Christophe Richez
    Estibaliz Lazaro
    Pierre Duffau
    Patrick Blanco
    Current Rheumatology Reports, 2017, 19
  • [50] Flavonoids and Platelet-Derived Thrombotic Disorders
    Lopez, Jose J.
    El Haouari, Mohammed
    Jardin, Isaac
    Alonso, Nieves
    Regodon, Sergio
    Diez-Bello, Raquel
    Redondo, Pedro C.
    Rosado, Juan A.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (39) : 7035 - 7047